Cardiff Oncology, Inc. (CRDF) stock
CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.89+0.05 (+6.39%)
Close on Nov 19, 2026Market cap $69.44MP/E –Yield –
Cardiff Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cardiff Oncology's enterprise value was $17.92M on Nov 11, 2026, against $92.38M a year earlier. Over the last 5 years it ranged from -$84.57M to $190.36M, with a median of $33.56M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $17.92M | -86.0% |
| 2025 | Dec 31, 2025 | $127.94M | -16.8% |
| 2024 | Dec 31, 2024 | $153.79M | – |
| 2023 | Dec 29, 2023 | -$15.28M | – |
| 2022 | Dec 30, 2022 | -$53.63M | -151.7% |
| 2021 | Dec 31, 2021 | $103.71M | -76.2% |
| 2020 | Dec 31, 2020 | $436.48M | – |
| 2019 | Dec 31, 2019 | -$1.05M | – |
| 2018 | Dec 31, 2018 | -$2.90M | -150.2% |
| 2017 | Dec 29, 2017 | $5.77M | -86.3% |
| 2016 | Dec 30, 2016 | $42.20M | -58.5% |
| 2015 | Dec 31, 2015 | $101.62M | +56.7% |
| 2014 | Dec 31, 2014 | $64.85M | -20.1% |
| 2013 | Dec 31, 2013 | $81.16M | -10.3% |
| 2012 | Dec 31, 2012 | $90.46M | – |
See a number that looks wrong?